China Resources Pharmaceutical Group (HKG:3320) agreed to cooperate with China Resources Bank of Zhuhai and China Resources SZITIC Trust for another three years, a Tuesday Hong Kong bourse filing said.
Under the renewed agreement, the company will utilize the CR Bank's financial services and products including the provision of letters of credit, guarantees, loans with collaterals, bills of exchange, and discount services among others.
For the cooperation with the CR Trust, the group may utilize the services and products from the CR Trust including cash management, asset management, custodian trust loan services, and assignment of receivables among others.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.